240 related articles for article (PubMed ID: 35211758)
1. RASSF10 exhibits tumor‑suppressing potential involving tumor proliferation, metastasis and epithelial‑mesenchymal transition in esophageal squamous cell carcinoma.
Liu Y; Zhu X; Zhang W; Bian T; Wu Z; Zhang J; Qiu H; Hu Y; Feng J; Shi J
Oncol Rep; 2022 Apr; 47(4):. PubMed ID: 35211758
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA‑181a promotes epithelial‑mesenchymal transition in esophageal squamous cell carcinoma via the TGF‑β/Smad pathway.
Xu R; Zhou XM; Li YS; Ren L; He XR
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760133
[TBL] [Abstract][Full Text] [Related]
3. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
[TBL] [Abstract][Full Text] [Related]
4. RUNX3 inhibits the invasion and migration of esophageal squamous cell carcinoma by reversing the epithelial‑mesenchymal transition through TGF‑β/Smad signaling.
Xiao Z; Tian Y; Jia Y; Shen Q; Jiang W; Chen G; Shang B; Shi M; Wang Z; Zhao X
Oncol Rep; 2020 Apr; 43(4):1289-1299. PubMed ID: 32323849
[TBL] [Abstract][Full Text] [Related]
5. BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis.
Zhao Y; Gao J; Xie X; Nan P; Liu F; Sun Y; Zhao X
Cancer Med; 2021 May; 10(10):3413-3426. PubMed ID: 33932125
[TBL] [Abstract][Full Text] [Related]
6. Long non‑coding RNA DLX6‑AS1 is associated with malignant progression and promotes proliferation and invasion in esophageal squamous cell carcinoma.
Wang M; Li Y; Yang Y; Liu X; Zang M; Li Y; Yang K; Yang W; Zhang S
Mol Med Rep; 2019 Mar; 19(3):1942-1950. PubMed ID: 30592268
[TBL] [Abstract][Full Text] [Related]
7. PURα mediates epithelial-mesenchymal transition to promote esophageal squamous cell carcinoma progression by regulating Snail2.
Gao J; Tian L; Sun Y; Li W; Zhao L; Sun Y; Jing Z; Zhou L; Liu F; Zhao X
Cancer Lett; 2021 Feb; 498():98-110. PubMed ID: 33144099
[TBL] [Abstract][Full Text] [Related]
8. MARCKSL1 interacted with F-actin to promote esophageal squamous cell carcinoma mobility by modulating the formation of invadopodia.
Zhao Y; Xie X; Tian L; Liu F; Sun Y; Lu H; Zhao X; Mao Y
Cancer Med; 2023 Feb; 12(3):3299-3312. PubMed ID: 35894387
[TBL] [Abstract][Full Text] [Related]
9. NEFL promotes invasion and migration of esophageal squamous carcinoma cells via the EGFR/AKT/S6 pathway.
Fan ZL; Yang LY; Zhang N; Feng D; Guo J; Chang C; Yuan Q; Cai Y; Zhang Y; Wei WQ; Wang MR; Hao JJ
Yi Chuan; 2022 Apr; 44(4):322-334. PubMed ID: 35437240
[TBL] [Abstract][Full Text] [Related]
10. EphA3 inhibits migration and invasion of esophageal cancer cells by activating the mesenchymal‑epithelial transition process.
Chen X; Lu B; Ma Q; Ji CD; Li JZ
Int J Oncol; 2019 Feb; 54(2):722-732. PubMed ID: 30483759
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA‑590 inhibits migration, invasion and epithelial‑to‑mesenchymal transition of esophageal squamous cell carcinoma by targeting low‑density lipoprotein receptor‑related protein 6.
Guan H; Liu J; Lv P; Zhou L; Zhang J; Cao W
Oncol Rep; 2020 Oct; 44(4):1385-1392. PubMed ID: 32945478
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA RP11-766N7.4 functions as a tumor suppressor by regulating epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Yao GL; Pan CF; Xu H; Wei K; Liu B; Zhai R; Chen YJ
Biomed Pharmacother; 2017 Apr; 88():778-785. PubMed ID: 28157654
[TBL] [Abstract][Full Text] [Related]
13. TESC acts as a prognostic factor and promotes epithelial-mesenchymal transition progression in esophageal squamous carcinoma.
Dong Y; Fan B; Li M; Zhang J; Xie S; Di S; Jia Q; Gong T
Pathol Res Pract; 2024 Jan; 253():154964. PubMed ID: 38000203
[TBL] [Abstract][Full Text] [Related]
14. Effects of miR‑106b‑3p on cell proliferation and epithelial‑mesenchymal transition, and targeting of ZNRF3 in esophageal squamous cell carcinoma.
Qiao G; Dai C; He Y; Shi J; Xu C
Int J Mol Med; 2019 Apr; 43(4):1817-1829. PubMed ID: 30816445
[TBL] [Abstract][Full Text] [Related]
15. FAM107A as a tumor suppressor in esophageal squamous carcinoma inhibits growth and metastasis.
Zhang J; Di S; Li M; Dong Y; Xie S; Gong T; Hu P; Jia Q; Fan B
Pathol Res Pract; 2023 Dec; 252():154945. PubMed ID: 37977035
[TBL] [Abstract][Full Text] [Related]
16. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma.
Han Q; Zhang HY; Zhong BL; Wang XJ; Zhang B; Chen H
Med Sci Monit; 2016 Oct; 22():3925-3934. PubMed ID: 27771733
[TBL] [Abstract][Full Text] [Related]
18. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
[TBL] [Abstract][Full Text] [Related]
19. LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation.
Cai R; Wang P; Zhao X; Lu X; Deng R; Wang X; Su Z; Hong C; Lin J
J Transl Med; 2020 Mar; 18(1):139. PubMed ID: 32216815
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA LINC00675 inhibits tumorigenesis and EMT via repressing Wnt/β-catenin signaling in esophageal squamous cell carcinoma.
Zhong YB; Shan AJ; Lv W; Wang J; Xu JZ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8288-8297. PubMed ID: 30556869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
